TIM-4 (CT) Blocking Peptide

TIM-4 (CT) Blocking Peptide

Product No.: T350

[product_table name="All Top" skus="T350"]

- -
- -
Target
TIM-4
Product Type
Blocking Peptide
Alternate Names
T Cell Immunoglobulin and Mucin Domain Containing Protein 4, T Cell Membrane Protein 4, SMUCKLER

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Product Concentration
0.2 mg/ml
Amino Acid Location
15 amino acids near the carboxy terminus of human TIM-4.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Background
TIM4 peptide is known as T cell immunoglobulin and mucin domain containing protein-4 and is a control peptide for blocking antibody binding in Western blotting.

Antigen Details

References & Citations

1. Chicheportiche Y, Bourdon PR, Xu H, et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 1997; 272:32401-10. 2. Lynch CN, Wang YC, Lund JK, et al. TWEAK induces angiogenesis and proliferation of endothelial cells. J. Biol. Chem. 1999; 274:8455-9. 3. Chicheportiche Y, Chicheportiche R, Sizing I, et al. Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies. Arthr. Res. 2002; 4:126-33. 5. Kaplan MJ, Lewis EE, Shelden EA, et al. The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells. J. Immunol. 2002; 169:6020-9.
Products are for research use only. Not for use in diagnostic or therapeutic procedures.